IBDEI1M8 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,699,0)
 ;;=ULTRASOUND^15^57
 ;;^UTILITY(U,$J,358.4,700,0)
 ;;=NEUROMUSCULAR RE-EDUCATION^10^57
 ;;^UTILITY(U,$J,358.4,701,0)
 ;;=INITIAL EVAL FOR TBI^13^58
 ;;^UTILITY(U,$J,358.4,702,0)
 ;;=INJURY/TRAUMA (SEQUELA)^14^58
 ;;^UTILITY(U,$J,358.4,703,0)
 ;;=LATE EFFECTS OF CVA^15^58
 ;;^UTILITY(U,$J,358.4,704,0)
 ;;=AMPUTATION STATUS^1^58
 ;;^UTILITY(U,$J,358.4,705,0)
 ;;=AUDITORY^3^58
 ;;^UTILITY(U,$J,358.4,706,0)
 ;;=BACK DIAGNOSIS^4^58
 ;;^UTILITY(U,$J,358.4,707,0)
 ;;=BRAIN DISORDERS^5^58
 ;;^UTILITY(U,$J,358.4,708,0)
 ;;=CARDIOPULMONARY^6^58
 ;;^UTILITY(U,$J,358.4,709,0)
 ;;=COGNITION^8^58
 ;;^UTILITY(U,$J,358.4,710,0)
 ;;=COMPLICATION DUE TO^9^58
 ;;^UTILITY(U,$J,358.4,711,0)
 ;;=ARTHRITIS^2^58
 ;;^UTILITY(U,$J,358.4,712,0)
 ;;=FRACTURES^11^58
 ;;^UTILITY(U,$J,358.4,713,0)
 ;;=MENTAL DISORDERS^17^58
 ;;^UTILITY(U,$J,358.4,714,0)
 ;;=MUSCULOSKELETAL/CONNECTIV^18^58
 ;;^UTILITY(U,$J,358.4,715,0)
 ;;=GENERAL SIGNS/SYMPTOMS^12^58
 ;;^UTILITY(U,$J,358.4,716,0)
 ;;=POST JOINT REPLACEMENT^20^58
 ;;^UTILITY(U,$J,358.4,717,0)
 ;;=RHEUMATOID^22^58
 ;;^UTILITY(U,$J,358.4,718,0)
 ;;=PSYCHIATRIC-PSYCHOSOC-EMO^21^58
 ;;^UTILITY(U,$J,358.4,719,0)
 ;;=SPEECH AND LANGUAGE^24^58
 ;;^UTILITY(U,$J,358.4,720,0)
 ;;=FITTING/ADJUSTMENT/AFTERCARE^10^58
 ;;^UTILITY(U,$J,358.4,721,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^26^58
 ;;^UTILITY(U,$J,358.4,722,0)
 ;;=CERVICAL DDD^7^58
 ;;^UTILITY(U,$J,358.4,723,0)
 ;;=LUMBAR DDD^16^58
 ;;^UTILITY(U,$J,358.4,724,0)
 ;;=OSTEOARTHRITIS^19^58
 ;;^UTILITY(U,$J,358.4,725,0)
 ;;=SOMATIC DYSFUNCTION^23^58
 ;;^UTILITY(U,$J,358.4,726,0)
 ;;=THORACIC DDD^27^58
 ;;^UTILITY(U,$J,358.4,727,0)
 ;;=SPORTS PARTICIPATION^25^58
 ;;^UTILITY(U,$J,358.4,728,0)
 ;;=INJECTION^12^59
 ;;^UTILITY(U,$J,358.4,729,0)
 ;;=SKIN TEST^25^59
 ;;^UTILITY(U,$J,358.4,730,0)
 ;;=NURSING PROCEDURES^14^59
 ;;^UTILITY(U,$J,358.4,731,0)
 ;;=MINOR PROCEDURES^13^59
 ;;^UTILITY(U,$J,358.4,732,0)
 ;;=SPLINTS^26^59
 ;;^UTILITY(U,$J,358.4,733,0)
 ;;=EDUCATION/TRAINING^6^59
 ;;^UTILITY(U,$J,358.4,734,0)
 ;;=ALLERGY SHOTS^2^59
 ;;^UTILITY(U,$J,358.4,735,0)
 ;;=EKG^7^59
 ;;^UTILITY(U,$J,358.4,736,0)
 ;;=BEHAVIORAL CHANGE INTERVENTION^3^59
 ;;^UTILITY(U,$J,358.4,737,0)
 ;;=OTH PREVENTIVE MEDICINE SVCS^15^59
 ;;^UTILITY(U,$J,358.4,738,0)
 ;;=GYN PROCEDURES^8^59
 ;;^UTILITY(U,$J,358.4,739,0)
 ;;=RISK FACTOR REDUCTION^24^59
 ;;^UTILITY(U,$J,358.4,740,0)
 ;;=PREVENTIVE GROUP COUNSELING^17^59
 ;;^UTILITY(U,$J,358.4,741,0)
 ;;=PROLONGED SERVICE^21^59
 ;;^UTILITY(U,$J,358.4,742,0)
 ;;=IMMUNIZATION ADMINISTRATION^10^59
 ;;^UTILITY(U,$J,358.4,743,0)
 ;;=REPAIR-SIMPLE FACE/MUCOUS^22^59
 ;;^UTILITY(U,$J,358.4,744,0)
 ;;=REPAIR-SIMPLE SCALP/NK/TRUNK^23^59
 ;;^UTILITY(U,$J,358.4,745,0)
 ;;=PREVENTIVE MED-EST PT^18^59
 ;;^UTILITY(U,$J,358.4,746,0)
 ;;=PREVENTIVE MED-NEW PT^19^59
 ;;^UTILITY(U,$J,358.4,747,0)
 ;;=ADVANCE CARE PLANNING^1^59
 ;;^UTILITY(U,$J,358.4,748,0)
 ;;=HEALTH BEHAVIORAL ASSESSMENT^9^59
 ;;^UTILITY(U,$J,358.4,749,0)
 ;;=PHARMACY SERVICES^16^59
 ;;^UTILITY(U,$J,358.4,750,0)
 ;;=IMMUNIZATIONS^11^59
 ;;^UTILITY(U,$J,358.4,751,0)
 ;;=E-CONSULT REFERRAL^5^59
 ;;^UTILITY(U,$J,358.4,752,0)
 ;;=COVID-19 RELATED^4^59
 ;;^UTILITY(U,$J,358.4,753,0)
 ;;=PRINCIPLE CARE MANAGEMENT^20^59
 ;;^UTILITY(U,$J,358.4,754,0)
 ;;=NEW PATIENT^2^60
 ;;^UTILITY(U,$J,358.4,755,0)
 ;;=ESTABLISHED PATIENT^1^60
 ;;^UTILITY(U,$J,358.4,756,0)
 ;;=CONSULTATIONS^3^60
